美国FDA生物制品紫皮书数据库
(U.S. FDA Purple Book: Database of Licensed Biological Products)
商品名 申请号 产品号 BLA类型 非专利名称 剂型 给药途径 规格/剂量 产品形式 批准日期 申请人 市场状态 许可证状态 参考产品非专利名称 参考产品专利名称
Gonal-f 020378 003 351(a) follitropin alfa For Injection Subcutaneous 37.5IU Ampule 2004/03/25 EMD Serono, Inc. Disc Licensed N/A N/A
Gonal-f RFF 021765 001 351(a) follitropin alfa For Injection Subcutaneous 37.5IU Single-Dose Vial 2004/03/25 EMD Serono, Inc. Disc Licensed N/A N/A
Gonal-f RFF 021765 002 351(a) follitropin alfa For Injection Subcutaneous 75IU Single-Dose Vial 2004/03/25 EMD Serono, Inc. Rx Licensed N/A N/A
Gonal-f RFF 021765 003 351(a) follitropin alfa For Injection Subcutaneous 150IU Single-Dose Vial 2004/03/25 EMD Serono, Inc. Disc Licensed N/A N/A
Follistim AQ Cartridge 021211 001 351(a) follitropin beta Injection Subcutaneous 300IU/0.36ML Multi-Dose Cartridge 2004/03/23 Organon USA LLC, a subsidiary of Organon & Co. Rx Licensed N/A N/A
Follistim AQ Cartridge 021211 002 351(a) follitropin beta Injection Subcutaneous 600IU/0.72ML Multi-Dose Cartridge 2004/03/23 Organon USA LLC, a subsidiary of Organon & Co. Rx Licensed N/A N/A
Monoclate, Monoclate-P 103953 004 351(a) Antihemophilic Factor (Human) For Injection Intravenous 1500IU Vial 2004/03/04 CSL Behring LLC Disc Voluntarily Revoked N/A
Avastin 125085 001 351(a) bevacizumab Injection Intravenous 100MG/4ML (25MG/ML) Single-Dose Vial 2004/02/26 Genentech, Inc. Rx Licensed N/A N/A
Avastin 125085 002 351(a) bevacizumab Injection Intravenous 400MG/16ML (25MG/ML) Single-Dose Vial 2004/02/26 Genentech, Inc. Rx Licensed N/A N/A
Rhophylac 125070 001 351(a) Rho(D) Immune Globulin Intravenous (Human) Injection Intramuscular 1500IU/ML Pre-Filled Syringe 2004/02/12 CSL Behring AG Rx Licensed N/A
Rhophylac 125070 002 351(a) Rho(D) Immune Globulin Intravenous (Human) Injection Intravenous 1500IU/ML Pre-Filled Syringe 2004/02/12 CSL Behring AG Rx Licensed N/A
Erbitux 125084 001 351(a) cetuximab Injection Intravenous 100MG/50ML (2MG/ML) Single-Dose Vial 2004/02/12 Eli Lilly and Company Rx Licensed N/A N/A
Pegasys 103964 002 351(a) peginterferon alfa-2a Injection Subcutaneous 180MCG/0.5ML Pre-Filled Syringe 2004/01/07 pharmaand GmbH Rx Licensed N/A N/A
Flebogamma 5%, Flebogamma 5% Dif 125077 001 351(a) Immune Globulin Intravenous (Human) Injection Intravenous 0.5G/10ML Single-Dose Vial 2003/12/15 Instituto Grifols, S.A. Disc Licensed N/A
Flebogamma 5%, Flebogamma 5% Dif 125077 002 351(a) Immune Globulin Intravenous (Human) Injection Intravenous 2.5G/50ML Single-Dose Vial 2003/12/15 Instituto Grifols, S.A. Disc Licensed N/A
Flebogamma 5%, Flebogamma 5% Dif 125077 003 351(a) Immune Globulin Intravenous (Human) Injection Intravenous 5G/100ML Single-Dose Vial 2003/12/15 Instituto Grifols, S.A. Rx Licensed N/A
Flebogamma 5%, Flebogamma 5% Dif 125077 004 351(a) Immune Globulin Intravenous (Human) Injection Intravenous 10G/200ML Single-Dose Vial 2003/12/15 Instituto Grifols, S.A. Rx Licensed N/A
Aranesp 103951 020 351(a) darbepoetin alpha Injection Intravenous, Subcutaneous 25MCG/0.42ML Pre-Filled Syringe 2003/12/12 Amgen Inc. Disc Licensed N/A N/A
Aranesp 103951 021 351(a) darbepoetin alpha Injection Intravenous, Subcutaneous 25MCG/0.42ML Pre-Filled Syringe 2003/12/12 Amgen Inc. Rx Licensed N/A N/A
Aranesp 103951 022 351(a) darbepoetin alpha Injection Intravenous, Subcutaneous 40MCG/0.4ML Pre-Filled Syringe 2003/12/12 Amgen Inc. Disc Licensed N/A N/A
当前数据更新日期:2025年12月18日,更多信息请点击此处查询美国FDA药品数据库

数据库说明:

©2006-2025 DrugFuture->U.S. FDA Purple Book